Curza Inc
SALT LAKE CITY, UT · Founded 2021 · CIK 0001978799 · Biotech · Private
Small-molecule drugs for infectious diseases
curza.com →- Grants
- $12M
- 14 awards
- Sector median: 1
- Raised
- $367K
- 1 Form D · Jun 2023
- 40 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Natural product-inspired antibacterials with unique ribosomal binding | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Natural product inspired antibacterials with unique ribosomal binding | $598,770 | |
| Federal grant | Department of Health and Human Services · Phase I · Natural product-inspired antibacterials with unique ribosomal binding | $298,770 | |
| Federal grant | Department of Health and Human Services · Phase II · A new class of broad-spectrum antibacterials for treating MDR infections | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A new class of broad-spectrum antibacterials for treating MDR infections | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A new class of broad-spectrum antibacterials for treating MDR infections | $1,000,000 | |
| Private capital raised | Form D · SEC | $367,233 | |
| Federal grant | Department of Health and Human Services · Phase II · A New Class of Broad-Spectrum Antibacterial Agents to Treat Multi-Drug Resistant Pathogens | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A new class of antibiotic to address Antimicrobial Resistance | $999,998 | |
| Federal grant | Department of Health and Human Services · Phase II · A New Class of Broad-Spectrum Antibacterial Agents to Treat Multi-Drug Resistant Pathogens | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · New oral antibiotics focused on treating MDR Gram-negative infections | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A new class of antibiotic to address Antimicrobial Resistance | $999,997 | |
| Federal grant | Department of Health and Human Services · Phase II · A New Class of Broad-Spectrum Antibacterial Agents to Treat Multi-Drug Resistant Pathogens | $858,436 | |
| Federal grant | Department of Health and Human Services · Phase II · New oral antibiotics focused on treating MDR Gram-negative infections | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · New oral antibiotics focused on treating MDR Gram-negative infections | $1,000,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2606 | GSNO THERAPEUTICS, INC. | — | — |
| 2607 | ANEURYST, INC. | — | — |
| 2608 | GABAeron, Inc. | — | — |
| 2609 | Curza Inc | — | $367K |
| 2610 | BreStem Therapeutics, Inc. | — | $300K |
| 2611 | VERAMORPH LLC | — | $262K |
| 2612 | XCELL SCIENCE, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Robert ArmstrongDirector
- Lloyd CzaplewiskiDirector
- J. FlanaganDirector
- John KozarichDirector
- Richard McKoewnDirector
- Joseph SorensonDirector
- Charles TestaDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.